MDA Space Ltd. (MDA) Stock Price & How to Invest

MDA Space Ltd. (NYSE: MDA; TSX: MDA) is a Canadian space-technology company that builds and operates hardware and systems across the space economy. It runs three business areas: Satellite Systems (software-defined satellites under the MDA Aurora product line, plus payloads and antennas for low-, medium-, and geosynchronous-orbit constellations), Robotics and Space Operations (the Canadarm robotic arms, including the Canadarm3 program for NASA's lunar Gateway), and Geointelligence (Earth-observation imagery and analytics, anchored by the MDA Chorus radar constellation expected to launch in late 2026). Headquartered near Toronto with major operations in Montreal, MDA has decades of spaceflight heritage and supplies both commercial constellation customers and government and defense agencies.

MDA completed a roughly US$300 million IPO and NYSE dual-listing in March 2026, adding a US market alongside its long-standing Toronto listing. The investment picture is a profitable, growing contractor riding a wave of satellite-constellation and defense spending: revenue jumped in 2025 and again in early 2026 as it converts a multi-billion-dollar backlog into sales on programs like Telesat Lightspeed, Globalstar's next-generation network, and Canadarm3. The stock trades at a premium multiple that prices in continued growth, so it is sensitive to program schedules, customer funding, and backlog conversion.

MDA's revenue is concentrated in a handful of large, lumpy programs, so a delay, cancellation, or schedule slip (as seen when Telesat Lightspeed's in-service target moved into 2028 on a supplier chip issue) can move results materially. It carries execution and fixed-price contract risk on complex hardware, and free cash flow can be neutral to negative in heavy investment years due to factory expansion and chip development capex. The company reports in Canadian dollars and depends on government funding cycles and export approvals, adding currency and policy exposure. Competition from larger primes and vertically integrated players like SpaceX pressures pricing and contract wins. As a premium-multiple growth name, the stock is sensitive to sentiment, backlog conversion, and quarter-to-quarter program timing.

3 analysts publish price targets on MDA, averaging $44.52 against a $30.25 price as of August 2026, or +47.2%. The published targets run from $39.98 to $51.55, a narrow spread, and the ratings split 3 buy, 0 hold, 0 sell. Over the last six months there have been 2 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full MDA forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on MDA Space Ltd.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Satellite constellation buildout. MDA's largest segment builds software-defined satellites (MDA Aurora) and payloads for low-Earth-orbit and other constellations, and it opened a Montreal factory capable of up to 400 satellites per year. The most optimistic published target, $51.55, assumes this works close to its best case.

The case against. MDA's revenue is concentrated in a handful of large, lumpy programs, so a delay, cancellation, or schedule slip (as seen when Telesat Lightspeed's in-service target moved into 2028 on a supplier chip issue) can move results materially. The most pessimistic target, $39.98, is roughly what MDA is worth if this bites instead.

Read the full bull and bear case on MDA, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see MDA Space Ltd.'s investor relations page or your broker.

• Revenue (2025): ~CA$1.6 billion (up ~51% YoY)
• Revenue (Q1 2026): ~CA$464 million (up ~32% YoY)
• Adjusted EBITDA (Q1 2026): ~CA$91 million
• 2026 revenue guidance: ~CA$1.7 to 1.9 billion
• Backlog / pipeline: ~CA$3.7B backlog, ~CA$40B pipeline
• Market cap: ~US$5.5 billion

MDA is profitable and growing, with early-2026 revenue up about 32 percent year over year and full-year 2026 guidance for roughly CA$1.7 to 1.9 billion in revenue and CA$320 to 370 million in adjusted EBITDA (an 18 to 20 percent margin). It trades at a premium earnings multiple that prices in continued backlog conversion, and free cash flow is guided neutral to negative as it funds factory expansion and chip development. Figures are approximate and reported in Canadian dollars; the NYSE market cap is in US dollars.

If you want MDA exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

Other names that sit close to MDA: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get MDA exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (WARP, UFO), which spreads the position across many companies. Or build it into a focused thematic portfolio, so MDA sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where MDA fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

MDA Space (MDA) is a profitable, backlog-driven space contractor spanning robotics, satellite manufacturing, and geointelligence, and in a portfolio it behaves as a growth-oriented aerospace-and-defense holding whose value tracks program execution and backlog conversion rather than a steady large-cap.

Whether MDA is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MDA a buy or a sell?, and where the stock could go from here in the MDA stock forecast.

For income investors, whether MDA pays a dividend and how the payout looks is covered in does MDA pay a dividend? And to weigh MDA against a peer, read the full side-by-side comparisons: MDA vs LMT and MDA vs NOC.